Quintiles named best CRO in vaccine excellence awards

Friday, April 13, 2012 02:01 PM

Quintiles, a global biopharmaceutical services company, has been named “Best Clinical Research Organization” (CRO) in the Vaccine Industry Excellence (ViE) Awards 2012, which recognizes and celebrates the leaders, innovators and pioneers in the vaccines industry.

“This is a great honor to be recognized as the “Best CRO” at the World Vaccine Congress,” said Dr. Ellen Vigdorth, VP Allergy, Respiratory, Infectious Diseases and Vaccines. “It is a huge achievement and underscores our commitment to the development of quality vaccines and anti-infective products.

Customers voted for their preferred CRO prior to the World Vaccine Congress; a judging panel then made its selection based on the following criteria: 1) Range of services provided in niche and core therapeutic areas; 2) Methods of performance improvement or introduction of new services; 3) Attention to and quality of relationships with clients; 4) Reaching of milestones and final/ongoing outcomes; 5) Building and maintaining existing and long-term partnerships.

This award comes shortly after Quintiles was named, for the second year running, the 2012 “Asia Pacific CRO of the Year” at the BioPharma Convention Awards.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 17

PPD, Medidata join their technologies for risk-based monitoring, adaptive trial design

ERT acquires eClinical Insights in "strategic combination" to gain cloud-based trial software platform, expertise

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs